HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours

NCT06708663 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Biliary Tract Cancer
Melanoma

Interventions

DRUG: HX009+IN10018

Sponsor

Hangzhou Hanx Biopharmaceuticals, Ltd.